PHASEBIO Trademark

Trademark Overview

On Thursday, September 6, 2018, a trademark application was filed for PHASEBIO with the United States Patent and Trademark Office. The USPTO has given the PHASEBIO trademark a serial number of 88107576. The federal status of this trademark filing is REGISTERED as of Tuesday, April 25, 2023. This trademark is owned by PhaseBio Pharmaceuticals, Inc.. The PHASEBIO trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for treating heart disease, heart conditions, hypertension, pulmonary hypertension, and other disorders of the cardiopulmonary system; pharmaceutical preparations consisting of reversal agents for counteracting the effects of platelet aggregation inhibitors
phasebio

General Information

Serial Number88107576
Word MarkPHASEBIO
Filing DateThursday, September 6, 2018
Status700 - REGISTERED
Status DateTuesday, April 25, 2023
Registration Number7037266
Registration DateTuesday, April 25, 2023
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 6, 2019

Trademark Statements

Goods and ServicesPharmaceutical preparations for treating heart disease, heart conditions, hypertension, pulmonary hypertension, and other disorders of the cardiopulmonary system; pharmaceutical preparations consisting of reversal agents for counteracting the effects of platelet aggregation inhibitors
Pseudo MarkPHASE BIO

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, September 14, 2018
Primary Code005
First Use Anywhere DateSaturday, February 29, 2020
First Use In Commerce DateSaturday, February 29, 2020

Trademark Owner History

Party NamePhaseBio Pharmaceuticals, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressMalvern, PA 19355
Party NamePhaseBio Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressMalvern, PA 19355
Party NamePhaseBio Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressMalvern, PA 19355

Trademark Events

Event DateEvent Description
Tuesday, April 25, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, April 25, 2023REGISTERED-PRINCIPAL REGISTER
Thursday, March 23, 2023NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Wednesday, March 22, 2023ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Thursday, March 16, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, March 15, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, March 15, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, October 24, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, October 24, 2022NON-FINAL ACTION E-MAILED
Monday, October 24, 2022SU - NON-FINAL ACTION - WRITTEN
Sunday, October 2, 2022STATEMENT OF USE PROCESSING COMPLETE
Friday, September 30, 2022USE AMENDMENT FILED
Friday, September 30, 2022TEAS STATEMENT OF USE RECEIVED
Thursday, February 24, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, February 23, 2022SOU EXTENSION 5 GRANTED
Wednesday, February 16, 2022SOU EXTENSION 5 FILED
Wednesday, February 23, 2022CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, February 16, 2022SOU TEAS EXTENSION RECEIVED
Wednesday, September 15, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, September 13, 2021SOU EXTENSION 4 GRANTED
Monday, September 13, 2021SOU EXTENSION 4 FILED
Monday, September 13, 2021SOU TEAS EXTENSION RECEIVED
Wednesday, March 17, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, March 15, 2021SOU EXTENSION 3 GRANTED
Monday, March 15, 2021SOU EXTENSION 3 FILED
Monday, March 15, 2021SOU TEAS EXTENSION RECEIVED
Friday, October 2, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, September 30, 2020SOU EXTENSION 2 GRANTED
Wednesday, September 30, 2020SOU EXTENSION 2 FILED
Wednesday, September 30, 2020SOU TEAS EXTENSION RECEIVED
Thursday, March 19, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, March 17, 2020SOU EXTENSION 1 GRANTED
Tuesday, March 17, 2020SOU EXTENSION 1 FILED
Tuesday, March 17, 2020SOU TEAS EXTENSION RECEIVED
Tuesday, October 1, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, August 6, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 6, 2019PUBLISHED FOR OPPOSITION
Wednesday, July 17, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, July 2, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, June 21, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, June 21, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, June 21, 2019ASSIGNED TO LIE
Monday, June 17, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, December 18, 2018NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, December 18, 2018NON-FINAL ACTION E-MAILED
Tuesday, December 18, 2018NON-FINAL ACTION WRITTEN
Monday, December 17, 2018ASSIGNED TO EXAMINER
Friday, September 14, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, September 10, 2018NEW APPLICATION ENTERED

Related Keywords

phasebio hypertension pharmaceutical heart preparations reversal agents counteracting platelet inhibitors aggregation